Pfizer, Valneva announce vaccination series completion in VALOR trial
PremiumThe FlyPfizer, Valneva announce vaccination series completion in VALOR trial
1M ago
Valneva’s Chikungunya Vaccine Wins European Approval
Premium
Company Announcements
Valneva’s Chikungunya Vaccine Wins European Approval
2M ago
Valneva Strengthens Board, Shareholders Back Plans
Premium
Company Announcements
Valneva Strengthens Board, Shareholders Back Plans
2M ago
Valneva’s Chikungunya Vaccine Nears EU Approval
PremiumCompany AnnouncementsValneva’s Chikungunya Vaccine Nears EU Approval
3M ago
Valneva announces positive CHMP opinion for chikungunya vaccine
Premium
The Fly
Valneva announces positive CHMP opinion for chikungunya vaccine
3M ago
EMA recommends authorization for Valneva’s chikungunya vaccine
Premium
The Fly
EMA recommends authorization for Valneva’s chikungunya vaccine
3M ago
Valneva Highlights Vaccine Advances at World Congress
PremiumCompany AnnouncementsValneva Highlights Vaccine Advances at World Congress
5M ago
Valneva price target lowered to $17 from $18 at Guggenheim
Premium
The Fly
Valneva price target lowered to $17 from $18 at Guggenheim
5M ago
Valneva SE Announces Strong Financial Growth and R&D Progress
Premium
Company Announcements
Valneva SE Announces Strong Financial Growth and R&D Progress
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100